Impact of Medicare Part D on out-of-pocket drug costs and medical use for patients with cancer.

摘要

Medicare D has reduced OOP prescription drug costs and outpatient visits for seniors with cancer beyond trends observed for younger patients, with no major impact on the use of other medical services noted.